Cynthia Egan Named Board of Visitors Chair Emerita in Recognition of Her Dedication and Leadership to UMSOM

University of Maryland School of Medicine Dean Mark T. Gladwin, MD, announced that former UMSOM Board of Visitors (BOV) Chair Cynthia Egan was honored for her service with the title of “Chair Emerita”.  Ms. Egan has served with distinction on the Board since 2013, with four years as Board Chair, until the recent appointment of Michael Greenebaum to that role.

“Cynthia Egan has been an invaluable member of the BOV and a personal mentor for me as a new Dean, bringing a wealth of experience and unique perspectives to the Board," said Dean Gladwin, who is the John Z. and Akiko K. Bowers Distinguished Professor and Dean, and Vice President for Medical Affairs, University of Maryland, Baltimore. "Her leadership and expertise in corporate governance, combined with her extensive operations management and marketing experience in the financial services industry, have greatly benefited the Board and the School of Medicine. We greatly appreciate her service and leadership."

During her tenure, she significantly increased member engagement on the BOV. Ms. Egan was deeply committed to fostering a strong culture of philanthropy, working closely with the Board collectively and individually to support the school's strategic vision. As Chair, she also demonstrated her leadership by delivering remarks at at numerous galas and diversity events over the years, including serving as the master of ceremonies for the 2022 School of Medicine Gala: Vision and Victories video program. Additionally, her personal philanthropic support has significantly contributed to various school initiatives.

As Chair Emerita, Ms. Egan continues to play an active role on the Board, with a focus on UM Shore Regional Health, R-HEALE, and other philanthropic initiatives on the Eastern Shore. She is particularly committed to advancing a national model for rural medicine and serves as a liaison with UM Shore Regional Health, which has become one of her top priorities. Ms. Egan's innovation, creativity, and dedication to the SOM's strategic vision will continue to propel the board's work, enriching discussions and fostering ideas for new initiatives.

Reflecting on her tenure, Ms. Egan said, "Chairing the Board of Visitors has been such a privilege, and I have this wonderful feeling of gratitude watching the progress that has been made during the last four years. I have tremendous optimism about the future of this institution and the leadership of Dean Gladwin and others. I genuinely believe that the School of Medicine is headed down the path of doing wonderful things for medicine and for our community.”

About the University of Maryland School of Medicine

Now in its third century, the University of Maryland School of Medicine was chartered in 1807 as the first public medical school in the United States. It continues today as one of the fastest growing, top-tier biomedical research enterprises in the world -- with 46 academic departments, centers, institutes, and programs, and a faculty of more than 3,000 physicians, scientists, and allied health professionals, including members of the National Academy of Medicine and the National Academy of Sciences, and a distinguished two-time winner of the Albert E. Lasker Award in Medical Research. With an operating budget of more than $1.2 billion, the School of Medicine works closely in partnership with the University of Maryland Medical Center and Medical System to provide research-intensive, academic, and clinically based care for nearly 2 million patients each year. The School of Medicine has more than $500 million in extramural funding, with most of its academic departments highly ranked among all medical schools in the nation in research funding. As one of the seven professional schools that make up the University of Maryland, Baltimore campus, the School of Medicine has a total population of nearly 9,000 faculty and staff, including 2,500 students, trainees, residents, and fellows. The School of Medicine, which ranks as the 8th highest among public medical schools in research productivity (according to the Association of American Medical Colleges profile) is an innovator in translational medicine, with 606 active patents and 52 start-up companies. In the latest U.S. News & World Report ranking of the Best Medical Schools, published in 2023, the UM School of Medicine is ranked #10 among the 92 public medical schools in the U.S., and in the top 16 percent (#32) of all 192 public and private U.S. medical schools. The School of Medicine works locally, nationally, and globally, with research and treatment facilities in 36 countries around the world. Visit: medschool.umaryland.edu.